Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Fazio

Showing results (11-20 of 284) with videos related to

Pageof 29
Sort By:
Journal of Atherosclerosis and Thrombosis|March 18, 2017
PCSK9 and Atherosclerosis - Lipids and BeyondMichael D Shapiro, Sergio Fazio
Current Opinion in Pharmacology|April 6, 2004
Cyclooxygenase-2 and inflammation in atherosclerosisMacRae F Linton, Sergio Fazio
The Journal of Clinical Endocrinology and Metabolism|September 9, 2006
Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary diseaseSergio Fazio, MacRae F Linton
Transactions of the American Clinical and Climatological Association|July 18, 2020
PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINESergio Fazio, Michael D Shapiro
Circulation Research|July 22, 2017
Setting the Agenda for Preventive CardiologyMichael D Shapiro, Sergio Fazio
Journal of the American College of Cardiology|May 5, 2012
Proprotein convertase subtilisin/kexin type 9 as transducer of physiologic influences on cellular cholesterol: a case for resistinSergio Fazio, MacRae F Linton
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2018
PREDICTING HYPERTRIGLYCERIDEMIC PANCREATITIS - NOT SO FAST!Michael D Shapiro, Sergio Fazio
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
6-Mercaptopurine, monocytes, and atherosclerosisMacrae F Linton, Sergio Fazio
Molecular Interventions|March 3, 2004
Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein?Sergio Fazio, MacRae F Linton
Lancet (London, England)|May 26, 2009
Fenofibrate and risk of minor amputations in diabetesSergio Fazio, MacRae F Linton
Pageof 29

Showing results (11-20 of 284) with videos related to

Sort By:
Pageof 29
Journal of Atherosclerosis and Thrombosis|March 18, 2017
PCSK9 and Atherosclerosis - Lipids and BeyondMichael D Shapiro, Sergio Fazio
Current Opinion in Pharmacology|April 6, 2004
Cyclooxygenase-2 and inflammation in atherosclerosisMacRae F Linton, Sergio Fazio
The Journal of Clinical Endocrinology and Metabolism|September 9, 2006
Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary diseaseSergio Fazio, MacRae F Linton
Transactions of the American Clinical and Climatological Association|July 18, 2020
PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINESergio Fazio, Michael D Shapiro
Circulation Research|July 22, 2017
Setting the Agenda for Preventive CardiologyMichael D Shapiro, Sergio Fazio
Journal of the American College of Cardiology|May 5, 2012
Proprotein convertase subtilisin/kexin type 9 as transducer of physiologic influences on cellular cholesterol: a case for resistinSergio Fazio, MacRae F Linton
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 25, 2018
PREDICTING HYPERTRIGLYCERIDEMIC PANCREATITIS - NOT SO FAST!Michael D Shapiro, Sergio Fazio
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
6-Mercaptopurine, monocytes, and atherosclerosisMacrae F Linton, Sergio Fazio
Molecular Interventions|March 3, 2004
Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein?Sergio Fazio, MacRae F Linton
Lancet (London, England)|May 26, 2009
Fenofibrate and risk of minor amputations in diabetesSergio Fazio, MacRae F Linton
Pageof 29